News & media

CLL Advocates December Newsletter

As you probably noted the interim report of the Pharmac Review Panel was released by Hon Andrew…

Continue reading

Neil Graham

CLL Advocates November Newsletter

Neil was the driving force and inspiring leader behind CLL Advocates and gave an enormous amount of…

Continue reading

SARS-CoV-2 IgG Serology Testing

This assay can potentially be used to assess vaccine response and to detect previous infection.

Continue reading

Request for Feedback – October Newsletter

Our monthly newsletter has now been going for a year and a half, and I’d like to hear back from you…

Continue reading

Media release: Where is the Pharmac Review Panel’s Report?

Patient advocacy groups and clinicians are calling out the Pharmac Review Panel for failing to get…

Continue reading

Global Leukemia Patient Experience Survey 2021

The CLL Advocates Network is asking for you to contribute to the 2021 Global Leukemia Patient…

Continue reading

‘I am screwed if it comes back’ Experts concerned by Covid’s hidden impact on blood cancer treatments

Around 21,000 Kiwis are living with blood cancer. Symptoms can be difficult to recognisegnise

Continue reading

WATCH – Blood Cancer Patient Forum 2021

The 2021 Blood Cancer Patient Forum. held virtually, is now available to view online.

Continue reading

CLL Horizons 2021 – 5-7 November 2021 – Register Now!

The CLL Horizons Conference is a unique opportunity for patient advocates and patient organization…

Continue reading

Living with CLL

WHAT IS THE DIFFERENCE BETWEEN CLL AND SLL?

Continue reading

Understanding your connection with Clinical Trials 2021

Andrew Schorr has kindly shared this on our CLL Advocates NZ Private Facebook Group which we…

Continue reading

Who will be eligible for a third Covid jab in the UK?

Half a million people will be offered another vaccine shot, with a decision on autumn boosters yet…

Continue reading

An expert hematologist/oncologist highlights

An expert hematologist/oncologist highlights key takeaways for the future management of chronic…

Continue reading

Update on treatment of Covid-19 in CLL patients

CLLANZ Newsletter August 2021

Continue reading

World CLL Day – 1 September

Every 1 September, the global CLL community unites to raise awareness about Chronic Lymphocytic…

Continue reading

Responses to COVID-19 Vaccines Vary in Patients With Hematologic Malignancies

Research has suggested that patients with hematologic malignancies may not mount an effective…

Continue reading

The Medicine Gap

The Medicine Gap is helping to provide a collective voice to the thousands and thousands of New…

Continue reading

Upcoming CLL events

Check out the CLL events coming up in the next few months

Continue reading

Pharmac commits to being more transparent

On 28 July for the first time Pharmac released its ‘Options for investment list’.

Continue reading

As a Cancer Patient, Will I Need an Extra Dose of a COVID-19 Vaccine?

This is the sixth in a multipart series exploring important questions about COVID-19 and its unique…

Continue reading

CLL and Dermatology

More than a quarter of CLL patients experience skin issues. On Thursday, August 12th, at 2 pm PDT/5…

Continue reading

Newsletter #13: Submission to Panel Reviewing Pharmac

Our major activity over the past month has been engaging with the independent Panel set up by the…

Continue reading

Covid-19 Vaccines May Not Produce Sufficient Antibody Response in Transplant Recipients

When clinical trials were conducted to determine the immunogenicity — the ability to elicit an…

Continue reading

CLL Advocates Newsletter Issue 12

Covid-19 and CLL prevention and treatment - an update.

Continue reading

Is there a link between CLL and stomach pain?

People with CLL may experience discomfort, swelling, and pain in the abdomen if their spleen…

Continue reading

CLL Advocates Newsletter Issue 11

Skin infection (cellulitis) and CLL - a cautionary tale

Continue reading

Attempting to target the tumor microenvironment leads the way to an array of potential targetable pathways in the disease..

According to the researchers, attempting to target the tumor microenvironment leads the way to an…

Continue reading

Medical specialist says Pharmac ‘wish list’ is a ‘necessity list’

Health expert discusses Pharmac's funding option list.

Continue reading

CLL Advocates Newsletter Issue 10

Welcome to issue 10 of the CLL Advocates newsletter.

Continue reading